| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Znf_C2H2-like | 2.39e-02 | 796 | 15 | 3 | IPR015880 | |
| Domain | ZnF_C2H2 | 2.49e-02 | 808 | 15 | 3 | SM00355 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.36e-05 | 358 | 17 | 4 | 32460013 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.01e-04 | 1024 | 17 | 5 | 24711643 | |
| Pubmed | 2.00e-04 | 622 | 17 | 4 | 14574404 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.24e-04 | 247 | 17 | 3 | 39238192 | |
| Pubmed | 2.34e-04 | 251 | 17 | 3 | 31076518 | ||
| Cytoband | 19p12 | 5.07e-04 | 90 | 17 | 2 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 9.28e-04 | 122 | 17 | 2 | chr19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.46e-02 | 503 | 17 | 2 | chr6p21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.38e-03 | 718 | 9 | 3 | 28 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-05 | 150 | 17 | 3 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 1.23e-05 | 199 | 17 | 4 | 6490_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.23e-05 | 199 | 17 | 4 | 7331_DN | |
| Drug | leucovorin | 1.17e-04 | 130 | 17 | 3 | CID000000143 | |
| Drug | leucine | 2.44e-04 | 167 | 17 | 3 | CID000000857 | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 1233_DN | |
| Drug | C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.74e-04 | 193 | 17 | 3 | 865_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 4597_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 5676_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2381_UP | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6271_UP | |
| Drug | doxycycline; Up 200; 14.4uM; MCF7; HT_HG-U133A_EA | 3.97e-04 | 197 | 17 | 3 | 1113_UP | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6636_UP | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4796_DN | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 7203_UP | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6225_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5219_DN | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 1670_UP | |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 7445_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6239_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 5050_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 4564_DN | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 7306_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 4959_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; HL60; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 2138_DN | |
| Drug | vitamin B12b | 4.87e-04 | 44 | 17 | 2 | CID004479097 | |
| Drug | glycylvaline | 5.33e-04 | 46 | 17 | 2 | CID000097417 | |
| Drug | DB04680 | 5.85e-04 | 225 | 17 | 3 | CID005326972 | |
| Drug | AC1MRBNS | 7.34e-04 | 54 | 17 | 2 | CID003465634 | |
| Drug | glycyl-L-leucine | 7.34e-04 | 54 | 17 | 2 | CID000092843 | |
| Disease | beta-Ala-His dipeptidase measurement | 7.70e-06 | 8 | 16 | 2 | EFO_0008033 | |
| Disease | end stage renal disease (is_implicated_in) | 2.23e-04 | 41 | 16 | 2 | DOID:783 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 6.15e-04 | 68 | 16 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | white matter lesion progression measurement | 6.70e-04 | 71 | 16 | 2 | EFO_0007746 | |
| Disease | Schizophrenia | 1.09e-03 | 883 | 16 | 4 | C0036341 | |
| Disease | alkaline phosphatase measurement | 1.82e-03 | 1015 | 16 | 4 | EFO_0004533 | |
| Disease | smoking status measurement, systolic blood pressure | 3.17e-03 | 156 | 16 | 2 | EFO_0006335, EFO_0006527 | |
| Disease | smoking status measurement, diastolic blood pressure | 3.29e-03 | 159 | 16 | 2 | EFO_0006336, EFO_0006527 | |
| Disease | hypertension | 1.18e-02 | 307 | 16 | 2 | EFO_0000537 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKYSPEKLIYADKKQ | 131 | Q86W67 | |
| EDVYEYYQKDPKNTK | 676 | Q8N7Z5 | |
| KYLENYYDLKKDVKQ | 36 | P08254 | |
| YFLAYEDKNDIPKEK | 71 | Q04760 | |
| TPKDYKEYKSYKDDS | 726 | Q9NYF8 | |
| LEYEIKYYEKDKEMQ | 471 | P29322 | |
| YKVYKDFLYKLSPKE | 256 | Q494V2 | |
| DYLYKDPKQQKIYDL | 871 | Q9NZC9 | |
| KEKYDTDFYILDKYP | 381 | P14868 | |
| SEGYYPISKKEKDKY | 1496 | O15047 | |
| ELKYDEKNKKAPEYY | 661 | Q9H8M5 | |
| KPYYQKKDITKEEYK | 1226 | Q9H7N4 | |
| DYDLEKKKKNREFYP | 401 | O43280 | |
| DKYEKKKYYDKNAIA | 121 | Q8IYB5 | |
| YKKDYAREKPYKCEE | 246 | Q8TD23 | |
| NEKYKKYVDENPLYE | 1161 | Q5VUA4 | |
| IYTEEKPYKCEEYNK | 231 | O75437 |